arXiv preprint ·
Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies
- Published
- Source
- arXiv preprint, posted before peer review
- Original
- Read it at arXiv
- Topics
Abstract
Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This simplifies the second stage to predicting pCR from inferred expression and clinical variables. Developed using 1,080 patients (five cohorts) and evaluated in 1,412 patients (nine cohorts), the model achieves a pooled AUROC of 0.79 (95% CI, 0.73-0.85), discriminating responders within molecular subtypes. It outperforms histopathological biomarkers, remaining stable across intratumoral sampling and with minimal biopsy tissue. Ablations show transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays' gene selection constraints. These results indicate that biologically informed compression may generalize to data-sparse applications in precision oncology.
The authors’ abstract, as arXiv lists it. arXiv’s listings, abstracts included, are free for anyone to reuse.
Read it on ReadSearch
Each opens after you create an account, and brings you back to this paper.
More in Artificial Intelligence
Time Series Forecasting Benchmarks Need Scenario-Grounded Stress Testing
How RL Reshapes LLM Reasoning: Transferability, Coverage, and Scaling Laws
VERSE: Verified Self-Evolving Optimizer for Agent Harnesses
Agentic Cognitive Depth: Operational Criteria for Evaluating LLM Agents
WebUIProof: Benchmarking WebUI Code Generators with UI-Agent Execution Harness
Get the few papers worth your time in Artificial Intelligence every morning.
ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.